Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 779853
                    [Title] => Price cuts eyed for more cancer drugs
                    [Summary] => 
To boost the campaign against cancer, the Department of Health (DOH) is now studying other anti-cancer drugs that can be subjected to mandatory price reduction.
                    [DatePublished] => 2012-02-23 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1804896
                    [AuthorName] => Sheila Crisostomo
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

QUALITY MEDICINES ACT

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 779853
                    [Title] => Price cuts eyed for more cancer drugs
                    [Summary] => 
To boost the campaign against cancer, the Department of Health (DOH) is now studying other anti-cancer drugs that can be subjected to mandatory price reduction.
                    [DatePublished] => 2012-02-23 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1804896
                    [AuthorName] => Sheila Crisostomo
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Price cuts eyed for more cancer drugs

By Sheila Crisostomo | February 23, 2012 - 12:00am

To boost the campaign against cancer, the Department of Health (DOH) is now studying other anti-cancer drugs that can be subjected to mandatory price reduction.

Science and Environment